Grant, Call number PAR-25-059
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
- , Add deadline: choose a calendar
- Institution applies
- Neuroscience, Neuropharmacology and
About
The IGNITE program supports early translational research to identify potential treatments for neurological and neuromuscular disorders. Projects develop assays and screen candidates, with a second phase contingent on milestones.
Topics
Eligibility
Covers: Phased R61/R33 support for assay development, screening and characterization of potential therapeutic agents.
Eligible organizations based outside the US may apply.
Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. Eligible organizations based outside the US may apply.
Source: simpler.grants.gov